Related Experiment Videos
Prostate Cancer Charitable Trust 2004 Forum: a personal overview
1CRUK Cancer and Immunogenetics Laboratory, Weatherall Institute for Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK. walter.bodmer@hertford.ox.ac.uk
Prostate Cancer and Prostatic Diseases
|November 17, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Histocompatibility 1984.
Immunology today·2014
Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
Journal of medical genetics·2006
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas.
Proceedings of the National Academy of Sciences of the United States of America·2002
APC mutations are sufficient for the growth of early colorectal adenomas.
Proceedings of the National Academy of Sciences of the United States of America·2000
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer.
Prostate cancer and prostatic diseases·2026
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.
Prostate cancer and prostatic diseases·2026
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.
Prostate cancer and prostatic diseases·2026
No racial disparities in prostate cancer-specific mortality after biochemical recurrence following radical prostatectomy or radiation therapy.
Prostate cancer and prostatic diseases·2026
Facilitators' champion behaviors for delivering an evidence-based parenting program.
American journal of community psychology·2026
Public health diplomacy in an era of complexity, uncertainty, and unpredictability: perspectives from a YFG-ASPHER workshop.
Frontiers in public health·2026
Policy in practice: Pathways to maximizing microbiologists' impact in UK policymaking.
Sustainable microbiology·2026
Why Evidence Is Not Enough: Power, Politics, and a Strategy Shift for Public Health.
The Milbank quarterly·2026